Annovis Bio (ANVS) said Thursday it has received a noncompliance notice from the New York Stock Exchange for market capitalization and stockholders' equity both below $50 million for 30 consecutive days.
It has notified the NYSE of its intention to submit a plan within 45 days detailing how it plans to regain listing compliance in the next 18 months, the company said in a statement.
The notice does not impact the company's operations or reporting obligations with the US Securities and Exchange Commission.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.